Cargando…

Milestones in Personalized Medicine in Pemphigus and Pemphigoid

Pemphigus and pemphigoid diseases are autoimmune bullous diseases characterized and caused by autoantibodies targeting adhesion molecules in the skin and/or mucous membranes. Personalized medicine is a new medical model that separates patients into different groups and aims to tailor medical decisio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bieber, Katja, Kridin, Khalaf, Emtenani, Shirin, Boch, Katharina, Schmidt, Enno, Ludwig, Ralf J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829330/ https://www.ncbi.nlm.nih.gov/pubmed/33505392 http://dx.doi.org/10.3389/fimmu.2020.591971

Ejemplares similares

Current Clinical Trials in Pemphigus and Pemphigoid
por: Izumi, Kentaro, et al.
Publicado: (2019)

The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study
por: Kridin, Khalaf, et al.
Publicado: (2021)

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
por: Khil'chenko, Stanislav, et al.
Publicado: (2020)

Mouse models of pemphigus: valuable tools to investigate pathomechanisms and novel therapeutic interventions
por: Emtenani, Shirin, et al.
Publicado: (2023)

Epidemiology of Pemphigus
por: Kridin, Khalaf, et al.
Publicado: (2021)

Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
por: Ghorbanalipoor, Saeedeh, et al.
Publicado: (2022)

Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
por: Ghorbanalipoor, Saeedeh, et al.
Publicado: (2022)

Sustained CD19(+)CD27(+) Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

Identification of novel therapeutic targets for blocking acantholysis in pemphigus
por: Burmester, Imke A.K., et al.
Publicado: (2020)

Anti-p200 Pemphigoid: A Systematic Review
por: Kridin, Khalaf, et al.
Publicado: (2019)

The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations
por: Kridin, Khalaf, et al.
Publicado: (2018)

Prevalence of pemphigus and pemphigoid autoantibodies in the general population
por: Prüßmann, Wiebke, et al.
Publicado: (2015)

Lichen Planus
por: Boch, Katharina, et al.
Publicado: (2021)

More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study
por: Ständer, Sascha, et al.
Publicado: (2020)

Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases
por: Bieber, Katja, et al.
Publicado: (2017)

The relevance of complement in pemphigoid diseases: A critical appraisal
por: Papara, Cristian, et al.
Publicado: (2022)

Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice
por: Hofrichter, Maxi, et al.
Publicado: (2018)

Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients
por: Kridin, Khalaf, et al.
Publicado: (2023)

Drug Development in Pemphigoid Diseases
por: BIEBER, Katja, et al.
Publicado: (2020)

Presence of Cutaneous Complement Deposition Distinguishes between Immunological and Histological Features of Bullous Pemphigoid—Insights from a Retrospective Cohort Study
por: Ständer, Sascha, et al.
Publicado: (2020)

The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal Study
por: Kridin, Khalaf, et al.
Publicado: (2019)

Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid
por: Rosi-Schumacher, Mattie, et al.
Publicado: (2023)

Editorial: Skin Autoimmunity
por: Kridin, Khalaf, et al.
Publicado: (2021)

Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients
por: Emtenani, Shirin, et al.
Publicado: (2022)

Analysis of T cell repertoires of CD45RO CD4 T cells in cohorts of patients with bullous pemphigoid: A pilot study
por: Niebuhr, Markus, et al.
Publicado: (2022)

Emerging treatment options for the management of pemphigus vulgaris
por: Kridin, Khalaf
Publicado: (2018)

Increased Risk of Pemphigus among Patients with Psoriasis: A Large-scale Cohort Study
por: KRIDIN, Khalaf, et al.
Publicado: (2020)

Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde Dehydrogenase
por: Patzelt, Sabrina, et al.
Publicado: (2022)

The Bidirectional Association Between Bullous Pemphigoid and Psoriasis: A Population-Based Cohort Study
por: Kridin, Khalaf, et al.
Publicado: (2020)

Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study
por: KRIDIN, Khalaf, et al.
Publicado: (2021)

Evaluation of clinical and laboratory characteristics of patients with cutaneous sarcoidosis: A single-center retrospective cohort study
por: Boch, Katharina, et al.
Publicado: (2022)

Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal study
por: Kridin, Khalaf, et al.
Publicado: (2021)

Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance
por: Tukaj, Stefan, et al.
Publicado: (2022)

Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris
por: Schinner, Jona, et al.
Publicado: (2023)

Incidence of Bullous Pemphigoid and Pemphigus in Korea
por: Joo, Jae Seong, et al.
Publicado: (2021)

Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2
por: Karsten, Christian M., et al.
Publicado: (2018)

Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders
por: Opelka, Bianca, et al.
Publicado: (2022)

Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models
por: Lotti, Roberta, et al.
Publicado: (2023)

HERPETIFORM PEMPHIGUS CLINICALLY RESEMBLING BULLOUS PEMPHIGOID
por: Mehta, Vandana, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_t5d4uvu6pvv68ji8cs4ge99m18